The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Stratasys sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Stratasys Ltd (Stratasys) offers services for additive manufacturing and 3D printing solutions. The company offers 3D printers, consumable materials and operating software suites. It also provides services such as strategic consulting, rapid prototyping, contract engineering, on-site installation, customer support and warranty, direct manufacturing paid-parts services, maintenance and training. Stratasys caters its solutions to government, and the businesses in aerospace, railways, healthcare, automotive, education and consumer product industries. It sells these products through direct sales teams, resellers and independent sales agents. The company has operations across the North America, Latin America, Europe, the Middle-East, Africa and Asia-Pacific. Stratasys is dual headquartered in Eden Prairie, Minnesota, the US. Key subsidiaries of Stratasys include Stratasys Direct, RP Support, Origin, Stratasys AP and Riven.ai.
The key metrics of Stratasys related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Stratasys is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Stratasys.